Sensitization of the mesoaccumbens dopamine response to nicotine

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 4, 1998, Pages 1021-1030

  Balfour, David J K ^a   Benwell, Maureen E M ^a   Birrell, Claire E ^a   Kelly, J ^a   Al Aloul, Mohamed ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Dependence; Dorsolateral striatum; Locomotor activity; Nicotine

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DRUG DEPENDENCE; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SMOKING;

ANIMALS; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; HUMANS; NICOTINE; NICOTINIC AGONISTS; NOMIFENSINE; NUCLEUS ACCUMBENS;

ANIMALIA; NICOTIANA TABACUM;

EID: 0032052206     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00537-6     Document Type: Article

References (56)

1. Agnati L. F., Zoli M., Stromberg I., Fuxe K. Intercellular communication in the brain. Wiring vs. volume transmission Neuroscience. 69:1995;711-726.
2. Altman J., Everitt B. J., Glautier S., Markou A., Nutt D., Oretti R., Phillips G. D., Robbins T. W. The biological, social and clinical aspects of drug addiction. Commentary and debate Psychopharmacology (Berlin). 125:1996;285-345.
3. Amador M., Dani J. A. MK-801 inhibition of nicotinic acetylcholine receptor channels. Synapse. 7:1991;207-215.
4. 3H] ABT-418. A novel cholinergic channel ligand J. Pharmacol. Exp. Ther. 270:1995;310-318.
5. Balfour D. J. K., Benwell M. E. M., Vale A. L. Studies on the role of mesolimbic dopamine in the behavioural responses to chronic nicotine. Adlkofer F., Thurau K. Effects of nicotine on biological systems. 1990;407-416 Birkhäuser Verlag, Berlin.
6. Balfour D. J. K., Fagerström K. O. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Pharmacol. Ther. 72:1996;51-81.
7. Benwell M. E. M., Balfour D. J. K. Nicotine binding to brain tissue from drug naive and nicotine-treated rats. J. Pharm. Pharmacol. 37:1985;405-409.
8. Benwell M. E. M., Balfour D. J. K. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br. J. Pharmacol. 105:1992;849-856.
9. Benwell M. E. M., Balfour D. J. K. The effect of ABT-418 on mesolimbic dopamine systems and locomotion in the rat. Br. J. Pharmacol. 119:1996;297.
10. Benwell M. E. M., Balfour D. J. K. Regional variation in the effects of nicotine on catecholamine overflow in the rat brain. Eur. J. Pharmacol. 325:1997;13-20.
11. Benwell M. E. M., Balfour D. J. K., Birrell C. E. Desensitisation of nicotine-induced dopamine responses during constant infusion with nicotine. Br. J. Pharmacol. 114:1995;211-217.
12. Benwell M. E. M., Balfour D. J. K., Lucchi H. M. The influence of tetrodotoxin and calcium on the stimulation of mesolimbic dopamine activity evoked by systemic nicotine. Psychopharmacology (Berlin). 112:1993;467-471.
13. Birrell C. E., Balfour D. J. K. Studies on the mechanisms underlying sensitisation of the mesoaccumbens dopamine response to nicotine in the rat. Br. J. Pharmacol. 115:1995;337.
14. 1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res. 692:1995;47-56.
15. Chergui K., Charlety P. J., Akaoka H., Saunier C. F., Brunet J.-L., Buda M., Svensson T. H., Chauvet G. Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur. J. Neurosci. 5:1993;137-144.
16. Clarke P. B. S. Dopaminergic mechanisms in the locomotor stimulant effects of nicotine. Biochem. Pharmacol. 40:1990;1427-1432.
17. Clarke P. B. S., Fu D. S., Jakubovic A., Fibiger H. C. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J. Pharmacol. Exp. Ther. 246:1988;701-708.
18. Clarke P. B. S., Kumar R. The effects of nicotine on locomotor activity in nontolerant and tolerant rats. Br. J. Pharmacol. 78:1983;329-337.
19. Clarke P. B. S., Pert A. Autoradiographical evidence for nicotinic receptors on nigrostriatal and mesolimbic dopaminergic neurones. Brain Res. 348:1985;355-358.
20. Corrigall W. A., Coen K. M., Adamson K. L. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res. 653:1994;278-284.
21. Corrigall W. A., Franklin K. J. B., Coen K. M., Clarke P. B. S. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berlin). 107:1992;285-289.
22. Di Chiara G. In vivo brain dialysis of neurotransmitters. Trends Pharmacol. Sci. 11:1990;116-121.
23. Garris P. A., Wightman R. M. Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex and striatum. An in vivo voltammetric study J. Neurosci. 14:1994;442-450.
24. Gonon F. G. Nonlinear relationship between impulse flow and dopamine released by rats midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience. 24:1988;19-28.
25. Grace A. A., Bunny B. S. The control of firing pattern in nigral dopamine neurons. Single spike firing J. Neurosci. 4:1984;2866-2876.
26. Grace A. A., Bunny B. S. The control of firing pattern in nigral dopamine neurons. burst firing J. Neurosci. 4:1984;2877-2890.
27. Gray R., Rajan A. S., Radcliffe K. A., Yakehiro M., Dani J. A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 383:1996;713-715.
28. Heimer L., Zahm D. S., Churchill L., Kalivas P. W., Wohltman C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience. 41:1991;89-125.
29. Henry D. J., Greene M. A., White F. J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system. repeated administration J. Pharmacol. Exp. Ther. 251:1989;833-839.
30. Imperato A., Mulas A., Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol. 132:1996;337-338.
31. Jones S. R., O'Dell S. J., Marshall J. F., Wightman R. M. Functional and anatomical evidence for different dopamine dynamics in the core and shell of the nucleus accumbens in slices of rat brain. Synapse. 23:1996;224-231.
32. Kalivas P. W. Neurotransmitter regulation of dopamine neurones in the ventral tegmental area. Brain Res. Rev. 18:1993;75-113.
33. Karler R., Calder L. D., Chaudry I. A., Turkanis S. A. Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801. Life Sci. 45:1989;599-606.
34. Karler R., Chaudry I. A., Calder L. D., Turkanis S. A. Amphetamine behavioral sensitization and the excitatory amino acids. Brain Res. 537:1990;76-82.
35. Mereu G., Yoon K.-W. P., Boi V., Gessa G. L., Naes L., Westfall T. C. Preferential stimulation of ventral tegmental area dopaminergic neurones by nicotine. Eur. J. Pharmacol. 141:1987;395-399.
36. Mitchell S. N. Role of the locus coeruleus in the noradrenergic response to a systemic administration of nicotine. Neuropharmacology. 32:1993;937-949.
37. Mitchell S. N., Brazell M. P., Joseph M. H., Alavijeh M. S., Gray J. A. Regionally specific effects of acute and chronic nicotine on rates of catecholamine and 5-hydroxytryptamine synthesis in rat brain. Eur. J. Pharmacol. 167:1989;311-322.
38. Museo E., Wise R. A. Locomotion induced by ventral tegmental microinjections of nicotinic agonist. Pharmacol. Biochem. Behav. 35:1990;735-737.
39. Museo E., Wise R. A. Microinjections of a nicotinic agonist into dopamine terminal fields. Effects on locomotion Pharmacol. Biochem. Behav. 37:1990;113-116.
40. Nicholls D. G. Proteins transmitters and synapses. 1994;Blackwell Scientific Publications, Oxford.
41. Nisell M., Nomikos G. G., Hertel P., Panagis G., Svensson T. H. Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat. Synapse. 22:1996;369-381.
42. Nisell M., Nomikos G. G., Svensson T. H. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse. 16:1994;36-44.
43. Nissbrandt H., Elverfors A., Engberg G. Pharmacologically induced cessation of burst activity in nigral dopamine neurons. Significance for terminal dopamine efflux Synapse. 17:1994;217-224.
44. Paxinos G., Watson W. The rat brain in stereotaxic coordinates. 2:1986;Academic Press, Sydney.
45. Pierce R. C., Kalivas P. W. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J. Pharmacol. Exp. Ther. 275:1995;1019-1029.
46. Pontieri F. E., Tanda G., Di Chiara G. Intravenous cocaine, morphine and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. USA. 92:1995;12304-12308.
47. Pontieri F., Tanda G., Orzi F., Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature. 382:1996;255-257.
48. Reavill C., Stolerman I. P. Locomotor activity in rats after administration of nicotinic agonist intracerebrally. Br. J. Pharmacol. 99:1990;273-278.
49. Robinson T. E., Berridge K. C. The neural basis of drug craving. An incentive-sensitization theory of addiction Brain Res. Rev. 18:1993;247-291.
50. Schenk S., Valadez A., McNamara C., House D. T., Higley D., Bankson M. G., Gibbs S., Horger B. A. Development and expression of sensitization to cocaine's reinforcing properties. Role of NMDA receptors Psychopharmacology (Berlin). 111:1993;332-338.
51. Shoaib M., Benwell M. E. M., Akbar M. T., Stolerman I. P., Balfour D. J. K. Behavioural and neurochemical adaptations to nicotine in rats. Influence of NMDA antagonists Br. J. Pharmacol. 111:1994;1073-1080.
52. Smith K. M., Mitchell S. N., Joseph M. H. Effects of chronic and subchronic nicotine on tyrosine hydroxylase activity in noradrenergic and dopaminergic neurones in the rat brain. J. Neurochem. 57:1991;1750-1756.
53. Stolerman I. P., Shoaib M. The neurobiology of nicotine addiction. Trends Pharmacol. Sci. 12:1991;467-473.
54. Vezina P., Herve D., Glowinski J., Tassin J. P. Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurones but spare the locomotor activating effects of nicotine in the rat. Neurosci. Lett. 168:1994;111-114.
55. Wonnacott S. Characterisation of nicotinic sites in the brain. Wonnacott S., Russell M. A. H., Stolerman I. P. Nicotine psychopharmacology. molecular, cellular and behavioural aspects:1990;226-277 Oxford University Press, Oxford.
56. Zoli M., Agnati L. F. Wiring and volume transmission in the central nervous system. the concept of closed and open synapses Prog. Neurobiol. 49:1996;363-380.